Teva Group and Actavis Generics - Company Facts & Figures
Teva is committed to developing and producing innovative and quality medicines for the patients we serve around the world. This is how we are helping people to live healthier lives.
Enabling access to quality medicines and treatment options
PT Actavis Indonesia site is a member of the Teva Group’s global operations network, which are routinely inspected for quality and good manufacturing practices by our global Quality Assurance team.
Quality control is not only from the global Teva Group, but also includes audits by the regulatory authorities of countries that market pharmaceutical products manufactured by PT Actavis Indonesia, such as Russia, Ukraine and many more.
In an effort to improve quality and capacity in producing international quality medicines, Actavis made major changes and improvements to our facility’s infrastructure, supporting equipment, production machinery and quality management. In recent years, PT Actavis Indonesia has also installed significant funds in conducting renovations in production buildings.
Focused specialty leadership centered on core therapeutic areas
Migraine and headache
Movement disorders and neurodegeneration
Global generic leadership
Top 3 leadership position in over 25 markets
A fully integrated R&D function
25 R&D and clinical development sites.